Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01204125
What this trial is testing

Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients

Who this might be right for
Breast Cancer Female
Sanofi 141
Early research (Phase 1)Study completedNCT03719326
What this trial is testing

Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

Who this might be right for
TNBC - Triple-Negative Breast CancerOvarian Cancer
Arcus Biosciences, Inc. 35
Not applicableLooking for participantsNCT07555210
What this trial is testing

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more
Jessica Mezzanotte Sharpe 25
Not applicableStudy completedNCT03457779
What this trial is testing

Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Baylor Research Institute 16
Early research (Phase 1)Study completedNCT03544125
What this trial is testing

Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor NegativeHER2/Neu Negative+3 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT02779855
What this trial is testing

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaInvasive Breast Carcinoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Not applicableEnded earlyNCT03750240
What this trial is testing

Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerTriple Negative Breast Cancer
NYU Langone Health 2
Early research (Phase 1)Looking for participantsNCT07311993
What this trial is testing

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Cellectar Biosciences, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00733408
What this trial is testing

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+3 more
University of Washington 59
Large-scale testing (Phase 3)Study completedNCT02425891
What this trial is testing

Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

Who this might be right for
Triple Negative Breast Cancer
Hoffmann-La Roche 902
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Testing effectiveness (Phase 2)Study completedNCT03316586
What this trial is testing

A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 18
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Looking for participantsNCT05491083
What this trial is testing

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer

Who this might be right for
Advanced Solid TumorTriple Negative Breast Cancer
National University Hospital, Singapore 51
Testing effectiveness (Phase 2)Study completedNCT01031446
What this trial is testing

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07458113
What this trial is testing

Sac-TMT for Active TNBC Brain Metastases

Who this might be right for
Metastatic Triple Negative Breast Cancers
Yale University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05852691
What this trial is testing

Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 83
Not applicableTemporarily pausedNCT02993068
What this trial is testing

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Who this might be right for
BARD1 Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+12 more
M.D. Anderson Cancer Center 5,200
Early research (Phase 1)UnknownNCT02977468
What this trial is testing

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Eileen Connolly 15
Next Page